ScoreWhy is Diaceutics Plc ?
1
Poor Management Efficiency with a low ROE of 0.95%
- The company has been able to generate a Return on Equity (avg) of 0.95% signifying low profitability per unit of shareholders funds
2
Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -1.06
- Poor long term growth as Operating profit has grown by an annual rate 6.03% of over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -1.06
- The company has been able to generate a Return on Equity (avg) of 0.95% signifying low profitability per unit of shareholders funds
3
Poor long term growth as Operating profit has grown by an annual rate 6.03% of over the last 5 years
4
Positive results in Dec 25
- ROCE(HY) Highest at 0.24%
- RAW MATERIAL COST(Y) Fallen by -14.88% (YoY)
- NET SALES(Q) Highest at GBP 23.87 MM
5
With ROE of 0.24%, it has a very attractive valuation with a 3.04 Price to Book Value
- Over the past year, while the stock has generated a return of 8.73%, its profits have risen by 105.9% ; the PEG ratio of the company is 1.2
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Diaceutics Plc should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Diaceutics Plc for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Diaceutics Plc
8.73%
0.51
32.90%
FTSE 100
18.59%
1.58
11.75%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
24.79%
EBIT Growth (5y)
6.03%
EBIT to Interest (avg)
-0.99
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.32
Sales to Capital Employed (avg)
0.60
Tax Ratio
14.30%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0.74%
ROE (avg)
0.95%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
123
Industry P/E
Price to Book Value
3.04
EV to EBIT
-116.06
EV to EBITDA
20.73
EV to Capital Employed
3.47
EV to Sales
3.02
PEG Ratio
1.16
Dividend Yield
NA
ROCE (Latest)
-0.63%
ROE (Latest)
0.24%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Bullish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend16What is working for the Company
ROCE(HY)
Highest at 0.24%
RAW MATERIAL COST(Y)
Fallen by -14.88% (YoY
NET SALES(Q)
Highest at GBP 23.87 MM
OPERATING PROFIT(Q)
Highest at GBP 6.25 MM
OPERATING PROFIT MARGIN(Q)
Highest at 26.17 %
PRE-TAX PROFIT(Q)
Highest at GBP 3.29 MM
NET PROFIT(Q)
Highest at GBP 2.5 MM
EPS(Q)
Highest at GBP 0.03
-3What is not working for the Company
CASH AND EQV(HY)
Lowest at GBP 7.34 MM
DEBT-EQUITY RATIO
(HY)
Highest at -15.3 %
DEBTORS TURNOVER RATIO(HY)
Lowest at 2.1 times
Here's what is working for Diaceutics Plc
Net Profit
At GBP 2.5 MM has Grown at 183.54%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (GBP MM)
Pre-Tax Profit
At GBP 3.29 MM has Grown at 142.85%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (GBP MM)
Net Sales
Highest at GBP 23.87 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (GBP MM)
Operating Profit
Highest at GBP 6.25 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (GBP MM)
Operating Profit Margin
Highest at 26.17 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at GBP 3.29 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (GBP MM)
Net Profit
Highest at GBP 2.5 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (GBP MM)
EPS
Highest at GBP 0.03
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (GBP)
Raw Material Cost
Fallen by -14.88% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
Highest at GBP 3.11 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (GBP MM)
Here's what is not working for Diaceutics Plc
Cash and Eqv
Lowest at GBP 7.34 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debt-Equity Ratio
Highest at -15.3 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Debtors Turnover Ratio
Lowest at 2.1 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
